The protective effect of auto-immune buccal urine therapy (AIBUT) against the Raynaud phenomenon.
The efficacy of Auto-Immune Buccal Urine Therapy (AIBUT) against allergic symptoms depends upon sublingual administration of the correct dose of urine as determined by bio-assay in individual patients. Succeeding effective turn-off doses occur at the troughs of a sinusoidal dose-response curve. Efficacy of the administered dose is confirmed by reduction in the severity and duration of Cold-water-induced Raynaud symptoms after administration of effective doses of unboiled urine in AIBUT. Boiled urine does not affect the Raynaud phenomenon.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000485:Allergens / Q000008:administration & dosage*; D003888:Desensitization, Immunologic / Q000379:methods*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005512:Food Hypersensitivity / Q000276:immunology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011928:Raynaud Disease / Q000628:therapy*; D012646:Self Administration; D013649:Taste; D014556:Urine
D000485:Allergens